Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin by Brown, Sarah D, Nativo, Paola, Smith, Jo-Ann, Stirling, David, Edwards, Paul R, Venugopal, Balaji, Flint, David J, Plumb, Jane A, Graham, Duncan, Wheate, Nial J

Get full text

Resilience of hospital and allied infrastructure during pandemic and post pandemic periods for maternal health care of pregnant women and infants in Tamil Nadu, India ‐ A counterfa... by Paramasivan, Kandaswamy, Prakash, Ashwin, Gupta, Sarthak, Phukan, Bhairav, M.R., Pavithra, Venugopal, Balaji

Get full text

VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penis by Nicholson, Steve, Tovey, Holly, Elliott, Tony, Burnett, Stephanie M, Cruickshank, Clare, Bahl, Amit, Kirkbride, Peter, Mitra, Anita V, Thomson, Alastair H, Vasudev, Naveen, Venugopal, Balaji, Slade, Rachel, Tregellas, Lucy, Morgan, Bruno, Hassall, Alison, Hall, Emma, Pickering, Lisa M

Get full text

Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma—Systematic Literature Review of Clinical and Real-World Evidence by Sharma, Anand, Bahl, Amit, Frazer, Ricky, Godhania, Esha, Halfpenny, Nicholas, Hartl, Kristina, Heldt, Dorothea, McGrane, John, Şahbaz Gülser, Sera, Venugopal, Balaji, Ritchie, Aimi, Crichton, Katherine

Get full text

The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel tr... by Ursprung, Stephan, Mossop, Helen, Gallagher, Ferdia A, Sala, Evis, Skells, Richard, Sipple, Jamal A N, Mitchell, Thomas J, Chhabra, Anita, Fife, Kate, Matakidou, Athena, Young, Gemma, Walker, Amanda, Thomas, Martin G, Ortuzar, Mireia Crispin, Sullivan, Mark, Protheroe, Andrew, Oades, Grenville, Venugopal, Balaji, Warren, Anne Y, Stone, John, Eisen, Tim, Wason, James, Welsh, Sarah J, Stewart, Grant D

Get full text

Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer by Rulach, Robert J., McKay, Stephen, Neilson, Sam, White, Lillian, Wallace, Jan, Carruthers, Ross, Lamb, Carolynn, Cascales, Almudena, Marashi, Husam, Glen, Hilary, Venugopal, Balaji, Sadoyze, Azmat, Sidek, Norma, Russell, J. Martin, Alhasso, Abdulla, Dodds, David, Laskey, Jennifer, Jones, Robert J., MacLeod, Nicholas

Get full text

The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis by Elyan, Benjamin M. P., Sullivan, Michael K., Hedley, James, De La Mata, Nicole, Webster, Angela C., Venugopal, Balaji, Jones, Rob J., Lang, Ninian N., Mark, Patrick B., Lees, Jennifer S.

Get full text

Clinical Practice Recommendations for Antithrombotic Management of Peripheral Artery Disease: An Indian Perspective by Pai, Paresh, Bedi, Varinder S, Kamerkar, Dhanesh R., George, Robbie, Rai, Kumud M, Gupta, P C, Sekhar, Raghuram, Balaji, Venugopal, Parakh, Rajiv, Subramanian, S.R., Thakore, Vijay, Sahu, Tapish, Jindal, Ravul

Get full text

Influence of tumor size in the progression of venous tumor thrombus in renal cell carcinoma: A 7-year single-center experience by Thangarasu, Mathisekaran, Prakash, J, Bafna, Sandeep, Aarthy, P, Govindaswamy, Thirumalai, Venugopal, Balaji, Sivaraman, Ananthakrishnan, Jain, Nitesh, Balakrishnan, Arunkumar, Raghavan, Deepak, Venkatraman, Murali, Chandranathan, M, Paul, Rajesh, Selvaraj, Nivash, Ramakrishnan, Balasubramaniam, Ragavan, Narasimhan

Get full text

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, plat... by James, Nicholas D, Prof, Sydes, Matthew R, MSc, Clarke, Noel W, Prof, Mason, Malcolm D, Prof, Dearnaley, David P, Prof, Spears, Melissa R, MSc, Ritchie, Alastair W S, MD, Parker, Christopher C, MD, Russell, J Martin, FRCR, Attard, Gerhardt, MD PhD, de Bono, Johann, Prof, Cross, William, PhD, Jones, Rob J, Prof, Thalmann, George, Prof, Amos, Claire, PhD, Matheson, David, PhD, Millman, Robin, Alzouebi, Mymoona, FRCR, Beesley, Sharon, FRCR, Birtle, Alison J, MD, Brock, Susannah, FRCR, Cathomas, Richard, MD, Chakraborti, Prabir, FRCR, Chowdhury, Simon, MD, Cook, Audrey, FRCR, Elliott, Tony, PhD, Gale, Joanna, DM, Gibbs, Stephanie, FRCR, Graham, John D, FRCP, Hetherington, John, FRCS[Eng], Hughes, Robert, FRCR, Laing, Robert, FRCR, McKinna, Fiona, FRCR, McLaren, Duncan B, FRCR, FRCP[Ed], O'Sullivan, Joe M, Prof, Parikh, Omi, FRCR, Peedell, Clive, FRCR, Protheroe, Andrew, PhD, Robinson, Angus J, FRCR, Srihari, Narayanan, MD, Srinivasan, Rajaguru, FRCR, Staffurth, John, MD, Sundar, Santhanam, FRCR, Tolan, Shaun, MD, Tsang, David, MCRP, Wagstaff, John, Prof, Parmar, Mahesh K B, Prof

Get full text

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, doubl... by Tomczak, Piotr, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Gross-Goupil, Marine, Burgents, Joseph E, Xu, Lei, Imai, Kentaro, Choueiri, Toni K, Venugopal, Balaji, Lin, Tzu-Ping, Symeonides, Stefan N., Sawrycki, Piotr, Haas, Naomi B., Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Doshi, Gurjyot, Melichar, Bohuslav, Kopyltsov, Evgeniy, Hammers, Hans-Joerg, Menezes, Juliana de Janoski, Winquist, Eric W., Hamzaj, Alketa, Karaszewska, Boguslawa, Lipatov, Oleg N., McDermott, David, Kochuparambil, Samith T., Davis, Ian D., Peltola, Katriina, Sabbatini, Roberto, Shkolnik, Michail I., McCune, Steven, Yeung, Carrie, Laguerre, Brigitte, Fomin, Eugeniy A., Zakharia, Yousef, Yorio, Jeffrey T., Yanez Ruiz, Eduardo, Kimura, Go, Nishimura, Kazuo, Masumori, Naoya, Kato, Haruaki, Sala Gonzalez, Nuria, Chiu, Kun-Yuan, Atkins, Michael B., Heath, Elisabeth, Feyerabend, Susan, Numakura, Kazuyuki, Zukov, Ruslan, Maroto Rey, Pablo Jose, Chang, Chao-Hsiang, Vengalil, Salil, Waddell, Tom S., Hauke, Ralph, Jayram, Gautam, Estay, Angela, Rubiano, Juan Andres, Anai, Satoshi, Tsunemori, Hiroyuki, Sikora-Kupis, Bozena, Gunderson, Elizabeth, Koletsky, Alan, Chen, Kevin, Agrawal, Manish, Parnis, Francis, Barbosa, Fernando Maciel, Faucher, Genevieve, Iqbal, Nayyer, Hanna, Nawar, Ibanez, Carolina, Manneh, Ray, Holeckova, Petra, Ronkainen, Hanna, Abadie-Lacourtoisie, Sophie, Goebell, Peter J., Hoefner, Thomas, Schultze-Seemann, Wolfgang, Yokomizo, Akira, Matsukawa, Yoshihisa, Murakami, Yoji, Kim, Miso, Szczylik, Cezary, Humphreys, Alison C., Kumar, Birendra, Karam, Jose Antonio, Fleming, Mark, Zarba, Juan Jose, Leiva, Viviana E., Antonio Junior, Joao Neif, Rocha, Roberto Odebrecht, Muniz, David, Brust, Leandro, Graham, Jeffrey, Borchiellini, Delphine, McDermott, Ray, Miura, Yuji, Prow, Debra M., Hashemi-Sadraei, Neda, Kendall, Stephan D.

Get full text

970 The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time by Elyan, Benjamin, Hedley, James, Sullivan, Michael, De La Mata, Nicole, Webster, Angela, Venugopal, Balaji, Jones, Rob, Lang, Ninian, Mark, Patrick, Lees, Jennifer

Get full text

A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma by Cook, Natalie, Basu, Bristi, Smith, Donna-Michelle, Gopinathan, Aarthi, Evans, Jeffry, Steward, William P, Palmer, Daniel, Propper, David, Venugopal, Balaji, Hategan, Mirela, Anthoney, D Alan, Hampson, Lisa V, Nebozhyn, Michael, Tuveson, David, Farmer-Hall, Hayley, Turner, Helen, McLeod, Robert, Halford, Sarah, Jodrell, Duncan

Get full text

Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma by Choueiri, Toni K, Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Symeonides, Stefan, Hajek, Jaroslav, Ferguson, Thomas, Chang, Yen-Hwa, Lee, Jae Lyun, Haas, Naomi, Sawrycki, Piotr, Sarwar, Naveed, Gross-Goupil, Marine, Thiery-Vuillemin, Antoine, Mahave, Mauricio, Kimura, Go, Perini, Rodolfo F, Saretsky, Todd L, Bhattacharya, Rituparna, Xu, Lei, Powles, Thomas

Get full text

Real-world Treatment Sequencing and Outcomes With Cabozantinib After First-line Immune Checkpoint Inhibitor-based Combination Therapy For Patients With Advanced Renal Cell Carcinom... by Nathan, Paul, Venugopal, Balaji, Ali, Jamshed, Allison, Jennifer, Ceruso, Mariangela, Charnley, Natalie, Griffiths, Richard, Michael, Agnieszka, Moore, Kathryn, Perrot, Valérie, Prendergast, Áine, Sharma, Anand, Szabados, Bernadett, Larkin, James

Get full text

42 Belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma: Subgroup analysis of the phase 3 LITESPARK-005 study by Albiges, Laurence, Choueiri, Toni K, Peltola, Katriina, de Velasco, Guillermo, Burotto, Mauricio, Suarez, Cristina, Ghatalia, Pooja, Iacovelli, Roberto, Lam, Elaine T, Verzoni, Elena, Gumus, Mahmut, Stadler, Walter M, Kollmannsberger, Christian, Melichar, Bohuslav, Venugopal, Balaji, Xing, Aiwen, Perini, Rodolfo F, Vickery, Donna, Rini, Brian, Powles, Thomas

Get full text

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA) by Stewart, Grant D, Welsh, Sarah J, Ursprung, Stephan, Gallagher, Ferdia A, Jones, James O, Shields, Jacqui, Smith, Christopher G, Mitchell, Thomas J, Warren, Anne Y, Bex, Axel, Boleti, Ekaterini, Carruthers, Jade, Eisen, Tim, Fife, Kate, Hamid, Abdel, Laird, Alexander, Leung, Steve, Malik, Jahangeer, Mendichovszky, Iosif A, Mumtaz, Faiz, Oades, Grenville, Priest, Andrew N, Riddick, Antony C P, Venugopal, Balaji, Welsh, Michelle, Riddle, Kathleen, Hopcroft, Lisa E M, Jones, Robert J

Get full text

Cabozantinib in the Routine Management of Renal Cell Carcinoma: A Systematic Literature Review of Real-World Evidence by Gross-Goupil, Marine, Bodnar, Lubomir, Campbell, Matthew T., Michael, Agnieszka, Venugopal, Balaji, Żołnierek, Jakub, Dutailly, Pascale, Procopio, Giuseppe, Albiges, Laurence

Get full text

A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advance... by VENUGOPAL, Balaji, BAIRD, Richard, SMIT, Johan W, FORSLUND, Ann, PHELPS, Charles, CAMM, John, EVANS, T. R. Jeffry, DE BONO, Johann S, BANERJI, Udai, KRISTELEIT, Rebecca S, PLUMMER, Ruth, COWAN, Richard, STEWART, Adam, FOURNEAU, Nele, HELLEMANS, Peter, ELSAYED, Yusri, MCCLUE, Steve

Get full text

Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical Outcomes by Venugopal, Balaji, Pillai, Manon, Powles, Thomas, Savage, Philip, Michael, Agnieszka, Fife, Kate, Klair, Bhupinder, Perrot, Valerie, Szabados, Bernadett

Get full text